OpenURL Connection Search

Select item for more details and to access through your institution.

Activation and potentiation of the NO/cGMP pathway by N G -hydroxyl-L-arginine in rabbit corpus cavernosum under normoxic and hypoxic conditions and ageing.
Published in:
British Journal of Pharmacology, 2003, v. 138, n. 1, p. 63, doi. 10.1038/sj.bjp.0705027
By:
- Angulo, Javier;
- Cuevas, Pedro;
- Fernández, Argentina;
- Gabancho, Sonia;
- Allona, Antonio;
- Martín-Morales, Antonio;
- Moncada, Ignacio;
- de Tejada, Iñigo Sáenz
Publication type:
Article
Testosterone treatment is not associated with increased risk of adverse cardiovascular events: results from the Registry of Hypogonadism in Men (RHYME).
Published in:
2016
By:
- Maggi, Mario;
- Wu, Frederick C.W.;
- Jones, Thomas H.;
- Jackson, Graham;
- Behre, Hermann M.;
- Hackett, Geoffrey;
- Martin‐Morales, Antonio;
- Balercia, Giancarlo;
- Dobs, Adrian S.;
- Arver, Stefan T.E.;
- Maggio, Marcello;
- Cunningham, Glenn R.;
- Isidori, Andrea M.;
- Quinton, Richard;
- Wheaton, Olivia A.;
- Siami, Flora S.;
- Rosen, Raymond C.;
- Meuleman, E.;
- Dohle, G.;
- Wu, F.
Publication type:
journal article
Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men.
Published in:
BJU International, 2017, v. 119, n. 2, p. 216, doi. 10.1111/bju.13578
By:
- Debruyne, Frans M.J.;
- Behre, Hermann M.;
- Roehrborn, Claus G.;
- Maggi, Mario;
- Wu, Frederick C.W.;
- Schröder, Fritz H.;
- Jones, Thomas Hugh;
- Porst, Hartmut;
- Hackett, Geoffrey;
- Wheaton, Olivia A.;
- Martin‐Morales, Antonio;
- Meuleman, Eric;
- Cunningham, Glenn R.;
- Divan, Hozefa A.;
- Rosen, Raymond C.;
- Dohle, G.;
- Arver, S.;
- Lenzi, A.;
- Stroberg, P.;
- Maggio, M.
Publication type:
Article
Effect of surgical approach on erectile function recovery following bilateral nerve-sparing radical prostatectomy: an evaluation utilising data from a randomised, double-blind, double-dummy multicentre trial of tadalafil vs placebo.
Published in:
BJU International, 2015, v. 116, n. 2, p. 241, doi. 10.1111/bju.13030
By:
- Stolzenburg, Jens‐Uwe;
- Graefen, Markus;
- Kriegel, Christian;
- Michl, Uwe;
- Martin Morales, Antonio;
- Pommerville, Peter J.;
- Manning, Martina;
- Büttner, Hartwig;
- Henneges, Carsten;
- Schostak, Martin
Publication type:
Article
Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study).
Published in:
2011
By:
- Jones TH;
- Arver S;
- Behre HM;
- Buvat J;
- Meuleman E;
- Moncada I;
- Morales AM;
- Volterrani M;
- Yellowlees A;
- Howell JD;
- Channer KS;
- TIMES2 Investigators;
- Jones, T Hugh;
- Arver, Stefan;
- Behre, Hermann M;
- Buvat, Jacques;
- Meuleman, Eric;
- Moncada, Ignacio;
- Morales, Antonio Martin;
- Volterrani, Maurizio
Publication type:
journal article
Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study).
Published in:
Diabetes Care, 2011, v. 34, n. 4, p. 828, doi. 10.2337/dc10-1233
By:
- JONES, T. HUGH;
- ARVER, STEFAN;
- BEHRE, HERMANN M.;
- BUVAT, JACQUES;
- MEULEMAN, ERIC;
- MONCADA, IGNACIO;
- MORALES, ANTONIO MARTIN;
- VOLTERRANI, MAURIZIO;
- YELLOWLEES, ANN;
- HOWELL, JULIAN D.;
- CHANNER, KEVIN S.
Publication type:
Article

Found: 6

Activation and potentiation of the NO/cGMP pathway by N G -hydroxyl-L-arginine in rabbit corpus cavernosum under normoxic and hypoxic conditions and ageing.

Testosterone treatment is not associated with increased risk of adverse cardiovascular events: results from the Registry of Hypogonadism in Men (RHYME).

Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men.

Effect of surgical approach on erectile function recovery following bilateral nerve-sparing radical prostatectomy: an evaluation utilising data from a randomised, double-blind, double-dummy multicentre trial of tadalafil vs placebo.

Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study).

Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study).